Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134.7 USD | +2.94% | +4.84% | +38.50% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.50% | 12.37B | |
-0.93% | 104B | |
+6.58% | 97.47B | |
+5.71% | 22.25B | |
-12.93% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.19% | 16.36B | |
+8.42% | 14.39B | |
+301.72% | 8.43B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Goldman Sachs Adjusts Sarepta Therapeutics Price Target to $215 From $188, Maintains Buy Rating